Theodore A. Boutacoff
Nessuna posizione attualmente
Profilo
Theodore A.
Boutacoff was the founder who founded IRIDEX Corp.
in 1989 and served as its Chief Technology Officer from 2011 to 2013.
He also worked as a Director at Biotheranostics, Inc. Additionally, he received his undergraduate degree from Stanford University.
Precedenti posizioni note di Theodore A. Boutacoff
| Società | Posizione | Fine |
|---|---|---|
| IRIDEX CORPORATION | Fondatore | 01/02/2013 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Formazione di Theodore A. Boutacoff
| Stanford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IRIDEX CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
- Borsa valori
- Insiders
- Theodore A. Boutacoff
